EX-23.2 8 a2018-10kxexhibit232co.htm EXHIBIT 23.2 Document


Exhibit 23.2
Consent of Independent Registered Public Accounting Firm

Cumberland Pharmaceuticals Inc.
Nashville, Tennessee


We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-221402) and Form S-8 (No. 333-164376) of Cumberland Pharmaceuticals Inc. of our report dated March 11, 2019, relating to the consolidated financial statements and financial statement schedule which appears in this Form 10-K.


/s/ BDO USA, LLP

Nashville, Tennessee
March 11, 2019